secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2022-08-26T23:59:59+00:00
Accession:  0001193125-22-231310
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta Pharmaceuticals enters ATM agreement with Jefferies for up to $100M common stock offering
--------------------------------------------------------------------------------

- Open Market Sale Agreement with Jefferies LLC allows at-the-market sales of up to $100M in common stock.
- Jefferies will receive a 3.0% commission on gross sales price per share sold under the agreement.
- Shares sold on Nasdaq Global Select Market or other trading venues; company has no obligation to sell.
- Offering terminates upon sale of all shares or termination of the agreement per its terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000119312522231310/0001193125-22-231310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000119312522231310/d376393d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-231310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer